Quest Diagnostics (DGX) Price Target Raised to $153 at Truist
Tweet Send to a Friend
Baird Eric Coldwell Neutral Quest Diagnostics (NYSE: DGX) price target of $153.00 (from $145.00).The analyst commented: "Maintain Neutral rating with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


